Evolus
EOLS
164 hedge funds and large institutions have $691M invested in Evolus in 2024 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 61 increasing their positions, 47 reducing their positions, and 17 closing their positions.
82% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 17
44% more capital invested
Capital invested by funds: $480M → $691M (+$211M)
30% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 47
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
12% more call options, than puts
Call options by funds: $8.41M | Put options by funds: $7.47M
9% more funds holding
Funds holding: 151 → 164 (+13)
0.57% more ownership
Funds ownership: 79.69% → 80.26% (+0.57%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$23.3M |
| 2 |
TCM
Tang Capital Management
San Diego,
California
|
+$13.6M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$10.8M |
| 4 |
CP
Caligan Partners
New York
|
+$7.42M |
| 5 |
Morgan Stanley
New York
|
+$5.98M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$34.6M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$4.36M |
| 3 |
Schroder Investment Management Group
London,
United Kingdom
|
-$4.27M |
| 4 |
Nuveen
Charlotte,
North Carolina
|
-$3.52M |
| 5 |
Renaissance Technologies
New York
|
-$3.1M |
EOLS Hedge Fund Activity: Q1 2024 in Review
164 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Evolus (EOLS) for Q1 2024, worth a combined $691M — up 44% from $480M a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new EOLS positions and 17 closed out — a net gain of 14 holders — while 61 added to existing stakes and 47 trimmed.
The largest buyer was Perceptive Advisors, adding an estimated $23.3M. The largest seller was Stonepine Capital Management, cutting an estimated $34.6M.
- 164 institutional investors held Evolus (EOLS) as of Q1 2024, up from 151 in Q4 2023.
- Funds reported $691M of Evolus stock for Q1 2024, up 44% quarter-over-quarter.
- 31 funds opened new Evolus positions in Q1 2024 and 17 closed out, a net change of +14 holders.
- The largest Evolus buyer in Q1 2024 was Perceptive Advisors, an estimated $23.3M added.
- The largest Evolus seller in Q1 2024 was Stonepine Capital Management, an estimated $34.6M sold.
Based on aggregated 13F filings for Q1 2024.